Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DTRMWXHS-12, a novel Bruton tyrosine kinase inhibitor, in combination with everolimus and pomalidomide in patients with relapsed/refractory lymphomas: An open-label, multicenter, phase 1a/1b study.
Huntington SF, Schuster SJ, Ding W, Koehler AB, Brander DM, Rosenthal AC, Leis JF, Tun HW, Moustafa MA, Iqbal M, He W, Kearney AS, McKinlay TP, Gui M, Mato AR. Huntington SF, et al. Among authors: tun hw. Am J Hematol. 2023 May;98(5):739-749. doi: 10.1002/ajh.26888. Epub 2023 Mar 7. Am J Hematol. 2023. PMID: 36810799 Free article. Clinical Trial.
Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL).
Shanafelt TD, Ramsay AG, Zent CS, Leis JF, Tun HW, Call TG, LaPlant B, Bowen D, Pettinger A, Jelinek DF, Hanson CA, Kay NE. Shanafelt TD, et al. Among authors: tun hw. Blood. 2013 May 16;121(20):4137-41. doi: 10.1182/blood-2012-12-470005. Epub 2013 Mar 14. Blood. 2013. PMID: 23493782 Free article. Clinical Trial.
A randomized trial of three novel regimens for recurrent acute myeloid leukemia demonstrates the continuing challenge of treating this difficult disease.
Litzow MR, Wang XV, Carroll MP, Karp JE, Ketterling RP, Zhang Y, Kaufmann SH, Lazarus HM, Luger SM, Paietta EM, Pratz KW, Tun HW, Altman JK, Broun ER, Rybka WB, Rowe JM, Tallman MS. Litzow MR, et al. Among authors: tun hw. Am J Hematol. 2019 Jan;94(1):111-117. doi: 10.1002/ajh.25333. Epub 2018 Nov 15. Am J Hematol. 2019. PMID: 30370956 Free PMC article. Clinical Trial.
C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel.
Melody M, Rahman ZA, Saunders H, Diaz PL, Gannon N, Rosenthal A, Ayala E, Tun HW, Murthy H, Roy V, Foran J, Castro JE, Guru P, Kharfan-Dabaja MA. Melody M, et al. Among authors: tun hw. Hematol Oncol Stem Cell Ther. 2021 Jun;14(2):141-146. doi: 10.1016/j.hemonc.2020.09.004. Epub 2020 Oct 13. Hematol Oncol Stem Cell Ther. 2021. PMID: 33069694 Free article.
Follicular lymphoma associated paraneoplastic myositis.
Melody M, Parrondo R, Alhaj Moustafa M, Wu K, Menke D, Seim L, Tun HW. Melody M, et al. Among authors: tun hw. Clin Case Rep. 2020 Jul 23;8(10):2003-2006. doi: 10.1002/ccr3.3046. eCollection 2020 Oct. Clin Case Rep. 2020. PMID: 33088539 Free PMC article.
Outcomes of Hepatosplenic T-Cell Lymphoma: The Mayo Clinic Experience.
Bojanini L, Jiang L, Tun AJ, Ayala E, Menke DM, Hoppe B, Kharfan-Dabaja MA, Tun HW, Alhaj Moustafa M. Bojanini L, et al. Among authors: tun hw, tun aj. Clin Lymphoma Myeloma Leuk. 2021 Feb;21(2):106-112.e1. doi: 10.1016/j.clml.2020.09.013. Epub 2020 Oct 5. Clin Lymphoma Myeloma Leuk. 2021. PMID: 33160933
97 results